(S)-Sunvozertinib, CAS [[2370013-49-1]]

Produktübersicht

• Artikelname: (S)-Sunvozertinib, CAS [[2370013-49-1]]
• Artikelnummer: BYT-ORB1298200
• Hersteller Artikelnummer: orb1298200
• Alternativnummer: BYT-ORB1298200-1,BYT-ORB1298200-5,BYT-ORB1298200-10,BYT-ORB1298200-25,BYT-ORB1298200-50,BYT-ORB1298200-100
• Hersteller: Biorbyt
• Kategorie: Biochemikalien
• Alternative Synonym: Btk, Bruton tyrosine kinase, (S) Sunvozertinib, (S)-DZD9008, (S)Sunvozertinib, (S)-Sunvozertinib, DZD 9008, DZD9008, DZD-9008, breast cancer, Epidermal growth factor receptor, ErbB-1, EGFR, HER2, HER1, Her2, Inhibitor, mutant forms of ErbB, inhibit, lung, N-[5-[[4-[5-Chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]pyrimidin-2-yl]amino]-2-[(3S)-3-(dimethylamino)pyrrolidin-1-yl]-4-methoxyphenyl]prop-2-enamide, Sunvozertinib

Produktbeschreibung

(S)-Sunvozertinib (DZD9008) is an irreversible, selective inhibitor targeting EGFR and HER2 tyrosine kinases. It is a research tool for investigating oncogenic mutations in preclinical models, demonstrating activity in both cellular assays and in vivo studies against EGFR-mutant cancers, including those with exon 20 insertions.

Produkteigenschaften

• Molekulargewicht: 584.08
• Reinheit: 99.69% (May vary between batches)
• CAS Nummer: [2370013-49-1]
• Formel: C29H35ClFN7O3
• Target-Kategorie: BTK,HER,EGFR

Anwendungsbeschreibung

• Anwendungsbeschreibung: Solubility: 10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (3.42 mM),DMSO:55 mg/mL (94.17 mM)